PT & Stock Review on Intersil Corporation (NASDAQ:ISIL), CVS Health Corporation (NYSE:CVS)

SHARE

Wall Street sell-side research analysts covering Intersil Corporation (NASDAQ:ISIL) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $21.333 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $22.5 while the most conservative estimate stand at $16.

Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover Intersil Corporation. They give the company shares an ABR of 3.14. This is based on the 6 analysts taken into consideration by Zacks.

Earnings Estimates for Intersil Corporation (NASDAQ:ISIL)

Currently, Wall Street is projecting that the firm will post $0.15 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2016-09-30, Intersil Corporation's EPS was reported as $0.18. This created a “surprise factor” 20% due to being $0.03 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.

Investors will mark their calendars for 2017-01-25, the date when Intersil Corporation (NASDAQ:ISIL) are expected to release their quarterly results.

Wall Street sell-side research analysts covering CVS Health Corporation (NYSE:CVS) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $100.428 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $122 while the most conservative estimate stand at $84.

Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover CVS Health Corporation. They give the company shares an ABR of 1.45. This is based on the 21 analysts taken into consideration by Zacks.

Earnings Estimates for CVS Health Corporation (NYSE:CVS)

Currently, Wall Street is projecting that the firm will post $1.67 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2016-09-30, CVS Health Corporation's EPS was reported as $1.64. This created a “surprise factor” 4.46% due to being $0.07 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.

Investors will mark their calendars for 2017-02-14, the date when CVS Health Corporation (NYSE:CVS) are expected to release their quarterly results.

LEAVE A REPLY